Veracyte Inc.

(VCYT) Trade

By |

Profile

Veracyte Inc is a genomic diagnostics company. It provides genomic diagnostic products and services to improve patient care against diseases such as thyroid cancer, lung cancer, and idiopathic pulmonary fibrosis. The firm's product portfolio consists of products such as Afirma analysis, Percepta, Envisia, and others. The company derives its revenues from the Sale of Afirma analysis product.

Contact Information

Website: www.veracyte.com
Email: keith@veracyte.com
Main Phone: +1 650 243-6300
Address: 6000 Shoreline Court
Address 2: Suite 300
State: CA
City / Town: South San Francisco
Country: US
Postal Code: 94080

Issuer Information

Exchange: NSD
CEO: Bonnie H. Anderson
Employees: 354
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

Profile

Veracyte Inc is a genomic diagnostics company. It provides genomic diagnostic products and services to improve patient care against diseases such as thyroid cancer, lung cancer, and idiopathic pulmonary fibrosis. The firm's product portfolio consists of products such as Afirma analysis, Percepta, Envisia, and others. The company derives its revenues from the Sale of Afirma analysis product.

Contact Information

Website: www.veracyte.com
Email: keith@veracyte.com
Main Phone: +1 650 243-6300
Address: 6000 Shoreline Court
Address 2: Suite 300
State: CA
City / Town: South San Francisco
Country: US
Postal Code: 94080

Issuer Information

Exchange: NSD
CEO: Bonnie H. Anderson
Employees: 354
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

$ 31.52 $ 0.55 (1.78%)
Last Price 31.52 Change $ 0.55 Change % 1.78 Tick N/A
Bid 29.52 Bid Size 400.00 Ask 48.00 Ask Size 100.00
Open 31.20 High 31.68 Low 30.21 Prev Close 30.97
Last Trade Volume 204,694 52 Wk Hi 36.42 52 Wk Low 13.90
Market Cap 1.8 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 57,482,246.00 EPS (TTM) -0.64 PE Ratio N/A Exchange NSD
  Last 3 Mo Last 12 Mo
Number of Insider Trades 3 22
Number of Buys 2 11
Number of Sells 1 11
Net Activity 25000 18401
Last 10 Buys Shares
Bonnie H. Anderson 1,000
Bonnie H. Anderson 1,000
Bonnie H. Anderson 1,000
Bonnie H. Anderson 1,000
Julie A. Brooks 1,000
Julie A. Brooks 1,000
Julie A. Brooks 1,000
Julie A. Brooks 1,000
Last 10 Sell Shares
Bonnie H. Anderson 1,000
Bonnie H. Anderson 1,000
Bonnie H. Anderson 1,000
Christopher Hall 1,000
Bonnie H. Anderson 1,000
Evan Jones 1,000
Evan Jones 1,000
Evan Jones 1,000
Evan Jones 1,000
Jesse I. Treu 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 10 10 10 10
Low Target Price Estimate 7 7 7 7
Mean Target Price Estimate 8.67 8.67 8.67 8.67
Standard Deviation 1.53 1.53 1.53 1.53
Date of Most Recent Estimate 05/02/18 05/02/18 05/02/18 05/02/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 3 3 3 3
Moderate Buy 0 0 0 0
Hold 2 2 2 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.8 1.8 1.8 1.8